Dr. Osondu Ogbuoji, Assistant Research Professor at the Duke Global Health Institute and Deputy Director at the Duke Center for Policy Impact in Global Health, presented research on a pooled-funding mechanism for clinical trials at the February CHDS seminar. The mechanism is designed to reduce disease burden of poverty-related and neglected diseases in low and middle-income countries.
Dr. Ogbuoji highlighted the pressing need for funding in this area, especially for expensive, late-stage clinical trials – a stage in the research and development (R&D) pipeline where promising new technologies often fail to attract the necessary funding from existing sources. The World Health Organization and others are developing a proposal for a pooled R&D fund to fill this gap. Dr. Ogbuoji presented an ongoing study from his team that aims to estimate the potential costs and benefits of such a funding mechanism.
This seminar is the second in a series of monthly online seminars hosted by CHDS. To be added to the email list for future seminars send a note to CHDS@HSPH.harvard.edu.
Learn more: Read about Osondu Ogbuoji and his work.
Learn more: Read about Markov Modeling and Discrete Event Simulation in Health Care: a Systematic Comparison